18 December 2020

Armand Bensussan awarded the Galien Prize 2020
18 December 2020

Professor Martine Bagot and Professor Armand Bensussan are rewarded for their research on the development of a targeted therapy, lacutamab, a monoclonal antibody targeting the tumor antigen KIR3DL2 for the treatment of patients with advanced, refractory and relapsed T cell lymphomas, particularly erythrodermic cutaneous T cell lymphomas. The Galien Prize here rewards two decades of research.
[ Read more ]
17 December 2020

AACR annual meeting 2021
17 December 2020

Jeremy BASTID, CEO of OREGA Biotech, will participate to the upcoming AACR annual meeting to be held virtually on April 10-15 and May 17-21, 2021.
[ Read more ]
15 December 2020

Season’s greetings
15 December 2020

From all of us at OREGA Biotech we wish you a wonderful holiday season and Merry Christmas !
[ Read more ]
16 October 2020

Anti CD39 mAb IPH5201 at EMSO 2020
16 October 2020

1073TiP A phase I, first-in-human, multicenter, open-label, dose-escalation study of IPH5201 as monotherapy or in combination with durvalumab ± oleclumab in advanced solid tumours. Download abstract.
[ Read more ]